96 related articles for article (PubMed ID: 1768971)
41. Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin.
Fanci R; Leoni F; Bosi A; Guidi S; Ciolli S; Longo G; Donnini E; Rossi Ferrini P
J Chemother; 1993 Apr; 5(2):119-23. PubMed ID: 8515294
[TBL] [Abstract][Full Text] [Related]
42. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.
Lew MA; Kehoe K; Ritz J; Antman KH; Nadler L; Takvorian T; Mayer R; Kalish L; Finberg R
Transplantation; 1991 Mar; 51(3):630-6. PubMed ID: 2006519
[TBL] [Abstract][Full Text] [Related]
43. Oral antimicrobial prophylaxis in bone marrow transplant recipients: randomized trial of ciprofloxacin versus ciprofloxacin-vancomycin.
Ford CD; Reilly W; Wood J; Classen DC; Burke JP
Antimicrob Agents Chemother; 1998 Jun; 42(6):1402-5. PubMed ID: 9624484
[TBL] [Abstract][Full Text] [Related]
44. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.
Broun ER; Wheat JL; Kneebone PH; Sundblad K; Hromas RA; Tricot G
Antimicrob Agents Chemother; 1994 Mar; 38(3):576-9. PubMed ID: 8203857
[TBL] [Abstract][Full Text] [Related]
45. [Comparison of ciprofloxacin with polymyxin B for infection prophylaxis in neutropenic patients with acute non-lymphocytic leukemia].
Moriuchi Y; Kamihira S; Yamamura M; Mori H; Miyazaki Y; Tokunaga S; Nonaka H; Amagasaki T; Yamada Y; Yoshida Y
Rinsho Ketsueki; 1990 Oct; 31(10):1664-9. PubMed ID: 2123946
[TBL] [Abstract][Full Text] [Related]
46. The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogeneic bone marrow transplantation.
Schots R; Trullemans F; Van Riet I; Kaufman L; Hafsia A; Meddeb B; Hadj Ali ZB; Ben Abid H; Lauwers S; Van Camp B
Transplantation; 2000 Apr; 69(7):1511-4. PubMed ID: 10798782
[TBL] [Abstract][Full Text] [Related]
47. High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group.
Wolff SN; Fay JW; Herzig RH; Greer JP; Dummer S; Brown RA; Collins RH; Stevens DA; Herzig GP
Ann Intern Med; 1993 Jun; 118(12):937-42. PubMed ID: 8489107
[TBL] [Abstract][Full Text] [Related]
48. [Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study].
Thomas X; Troncy J; Belhabri A; Thiebaut A; Bouheddou N; Michallet M; Fleurette J; Pivot C; Fiere D; Archimbaud E
Presse Med; 2000 Oct; 29(32):1745-51. PubMed ID: 11098268
[TBL] [Abstract][Full Text] [Related]
49. Long-term oral ciprofloxacin for infection prophylaxis in allogeneic bone marrow transplantation.
de Witte T; Novakova I; Branolte J; Muytjens H; de Pauw B
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S48-52. PubMed ID: 2963998
[TBL] [Abstract][Full Text] [Related]
50. Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.
Talbot GH; Cassileth PA; Paradiso L; Correa-Coronas R; Bond L
Antimicrob Agents Chemother; 1993 Mar; 37(3):474-82. PubMed ID: 8460916
[TBL] [Abstract][Full Text] [Related]
51. Infections in bone marrow transplant patients: use of reverse-barrier isolation.
Pretnar J; Cernelc P; Mlakar U
Transplant Proc; 1992 Oct; 24(5):2033. PubMed ID: 1412961
[No Abstract] [Full Text] [Related]
52. Prevention of bacterial and fungal infections in granulocytopenic patients.
Verhoef J; Rozenberg-Arska M; Dekker AW
Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1345-50. PubMed ID: 2680513
[TBL] [Abstract][Full Text] [Related]
53. Incidence of bacterial contamination of bone marrow grafts.
Schepers KG; Davis JM; Rowley SD
Prog Clin Biol Res; 1992; 377():379-84. PubMed ID: 1438434
[No Abstract] [Full Text] [Related]
54. Science and pragmatism in the treatment and prevention of neutropenic infection.
Klastersky J
J Antimicrob Chemother; 1998 Jun; 41 Suppl D():13-24. PubMed ID: 9688448
[TBL] [Abstract][Full Text] [Related]
55. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis.
Classen DC; Burke JP; Ford CD; Evershed S; Aloia MR; Wilfahrt JK; Elliott JA
Am J Med; 1990 Oct; 89(4):441-6. PubMed ID: 2171333
[TBL] [Abstract][Full Text] [Related]
56. Bacterial contamination of autologous bone marrow during processing.
Smith D; Bradley SJ; Scott GM
J Hosp Infect; 1996 May; 33(1):71-6. PubMed ID: 8738204
[TBL] [Abstract][Full Text] [Related]
57. Infection control issues after bone marrow transplantation.
Kusne S; Krystofiak S
Curr Opin Infect Dis; 2001 Aug; 14(4):427-31. PubMed ID: 11964860
[TBL] [Abstract][Full Text] [Related]
58. Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patients.
Lazarus HM; Creger RJ; Gucalp R; Fox RM; Ciobanu N; Carlisle PS; Cooper BW; Jacobs MR
Int J Antimicrob Agents; 1996 Jul; 7(2):85-91. PubMed ID: 18611741
[TBL] [Abstract][Full Text] [Related]
59. Value of surveillance cultures in a bone marrow transplantation unit.
Czirók E; Prinz GY; Dénes R; Reményi P; Herendi A
J Med Microbiol; 1997 Sep; 46(9):785-91. PubMed ID: 9291891
[TBL] [Abstract][Full Text] [Related]
60. Antiinfective prophylaxis with ceftazidime and teicoplanin in children undergoing high-dose chemotherapy and bone marrow transplantation.
Avril M; Hartmann O; Valteau-Couanet D; Brugieres L; Kalifa C; Lemerle J
Pediatr Hematol Oncol; 1994; 11(1):63-73. PubMed ID: 8155502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
